Trials / Completed
CompletedNCT00170300
Care-HF CArdiac Resynchronization in Heart Failure
Outcome Trial (Long Term)to Evaluate the Effects of Cardiac Resynchronization Therapy on the Mortality and Morbidity of Patients With Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 813 (planned)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The CARE-HF trial evaluates the effects of Cardiac Resynchronization (CR) therapy on the mortality and morbidity of patients with heart failure due to left ventricular systolic dysfunction already receiving diuretics and optimal medical therapy.
Detailed description
813 patients enrolled 82 centers in 12 countries (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, and UK)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Cardiac Resynchronisation (pacing) device |
Timeline
- Start date
- 2001-01-01
- Completion
- 2005-05-01
- First posted
- 2005-09-15
- Last updated
- 2025-07-03
Source: ClinicalTrials.gov record NCT00170300. Inclusion in this directory is not an endorsement.